ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

アルチカイン

Articaine

HCID 32170
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
23964-58-1
標準SMILES
CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC
InChIKey
QTGIAADRBBLJGA-UHFFFAOYSA-N
分子式
C13H20N2O3S
平均分子量
284.38 g/mol
単同位体質量
284.11946368

概要

4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic acid methyl ester is a thiophenecarboxylic acid.

名称と識別子

優先名称
Articaine
IUPAC
methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate
現地名
アルチカイン
英語名
Articaine
分子式
C13H20N2O3S
分子量
284.37

名称と別名

Articaine23964-58-1CarticaineArticainaArticainumArticadentArticainCarticainOrablocUltacanD3SQ406G9Xmethyl 4-methyl-3-[2-(propylamino)propanamido]thiophene-2-carboxylate
名称をさらに表示
4-メチル-3-[1-オキソ-2-(プロピルアミノ)プロピルアミノ]-2-チオフェンカルボン酸メチル4-メチル-3-[[1-オキソ-2-(プロピルアミノ)プロピル]アミノ]-2-チオフェンカルボン酸メチルカルチカインアルチカインウルトラカインメチル 4-メチル-3-[2-(プロピルアミノ)プロパンアミド]チオフェン-2-カルボキシラートARTICAINE HCL40045atecaineUnii-D3sq406G9xArticaine (USP)
DTXSID7048536methyl 4-methyl-3-(2-(propylamino)propanamido)thiophene-2-carboxylate2-Thiophenecarboxylic acid, 4-methyl-3-((1-oxo-2-(propylamino)propyl)amino)-, methyl esterUltacan ForteHydrochloride, CarticaineRefChem:388864Septocaine and EpinephrineArticaine HCl and Epinephrine

データベース識別子

CAS
23964-58-1
PubChem CID
32170
DTXSID
DTXSID7048536
ChEMBL
CHEMBL1093
ChEBI
CHEBI:91834
UNII
D3SQ406G9X
EC Number
607-295-0
Nikkaji
J342.299B

物性

構造計算による物性補完中

XLogP
2.8
極性表面積
95.7 Ų
水素結合供与体数
2
水素結合受容体数
5
回転可能結合数
7
重原子数
19
形式電荷
0
複雑度
325

実験および物理化学的性質

DrugsPharmaceuticals
Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Anesthetics, Local

FDA approved drugs -> Active ingredient

Pharmaceuticals

Melting Point172-173

物理化学的性質

融点
175 · 175-176 °C
沸点
0.3 · bp0.3 162-167°
比重(密度)
1.178 · 1.178±0.06 g/cm3(Predicted)
貯蔵温度
Refrigerator
溶解性
DMSO(微量)、メタノール(微量)
酸解離定数(Pka)
13.46 · 13.46±0.70(Predicted)
外見
個体
色
ホワイトからオフホワイト
主な用途
医薬品(低分子化合物)
InChI
InChI=1S/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-8(2)7-19-11(10)13(17)18-4/h7,9,14H,5-6H2,1-4H3,(H,15,16)
InChIKey
QTGIAADRBBLJGA-UHFFFAOYSA-N
SMILES
C1(C(OC)=O)SC=C(C)C=1NC(=O)C(NCCC)C
CAS データベース
23964 · 23964-58-1(CAS DataBase Reference)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk
WGK 3
hs_code
2934990002
Hazard Classifications
Acute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

ATC Code · 3 件

N01BB58

N - Nervous system

QN - Nervous system

FDA Pharmacological Classification · 6 件

D3SQ406G9X

ARTICAINE

Established Pharmacologic Class [EPC] - Amide Local Anesthetic

Chemical Structure [CS] - Amides

Physiologic Effects [PE] - Local Anesthesia

Articaine is an Amide Local Anesthetic. The physiologic effect of articaine is by means of Local Anesthesia.

MeSH Pharmacological Classification · 1 件

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

用途と製造

UsesUse (kg; approx.) in Germany (2009): >100
Use ClassificationPharmaceuticals
応用分野 · 2 件

説明Articaine [4-methyl-3-(2-propylaminopropionamido) thiophene-2-carboxylic acid methyl ester hydrochloride] has been widely used in dentistry since its approval by the U.S. FDA in the year 2000 because of its quick onset and short duration of action. The structure of articaine differs from those of all other amino amide-type local anesthetics in that it contains a thiophene ring instead of a benzene ring and a carbomethoxy group. This renders the molecule more lipophilic and, thus, easier to cross any lipoidal membranes. Its local anesthetic potency is approximately 1.5-fold that of lidocaine, even though it has similar pKa (7.8) and plasma protein binding (76%) properties. Articaine also is metabolized primarily by plasma cholinesterases because of the presence of an ester group and, therefore, has a much shorter duration of action than lidocaine (i.e., only approximately one-fourth that of lidocaine). Articaine undergoes rapid hydrolysis of the carbomethoxy group to give articainic acid, which is eliminated either unchanged (75%) or as its glucuronides (25%). Compared with to other shortacting, amino amide-type local anesthetics, such as mepivacaine, lidocaine, or prilocaine, articaine is said to be a much safer drug for regional anesthesia and is the drug of choice for dental procedures.

使用Articaine is an amide based short-acting local anesthetic use for regional anaesthesia in day-case settings such arthroscopy, hand , food surgery and in dentistry.

上流・下流製品情報

上流原料

3-クロロプロピオニルクロリドプロピルアミン

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート